nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—SLC6A14—obesity	0.792	1	CbGaD
Valganciclovir—Valaciclovir—SLC6A14—obesity	0.00365	0.713	CrCbGaD
Valganciclovir—SLC6A14—Na+/Cl- dependent neurotransmitter transporters—SLC22A1—obesity	0.00236	0.0654	CbGpPWpGaD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—HMGB2—obesity	0.00188	0.052	CbGpPWpGaD
Valganciclovir—SLC6A14—Amine compound SLC transporters—SLC22A1—obesity	0.00164	0.0454	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A7—obesity	0.00155	0.0428	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—CES1—obesity	0.00111	0.0308	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—ME1—obesity	0.00104	0.0287	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A3—obesity	0.000987	0.0273	CbGpPWpGaD
Valganciclovir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC6A14—obesity	0.000957	0.0265	CbGpPWpGaD
Valganciclovir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC6A14—obesity	0.000888	0.0246	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—FTL—obesity	0.000881	0.0244	CbGpPWpGaD
Valganciclovir—Ganciclovir—SLC22A1—obesity	0.000824	0.161	CrCbGaD
Valganciclovir—SLC6A14—digestive system—obesity	0.000823	0.315	CbGeAlD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC16A7—obesity	0.000702	0.0194	CbGpPWpGaD
Valganciclovir—SLC6A14—endocrine gland—obesity	0.00068	0.261	CbGeAlD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—obesity	0.000679	0.0188	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—PPARD—obesity	0.000653	0.0181	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—obesity	0.000642	0.0178	CbGpPWpGaD
Valganciclovir—Aciclovir—SLC22A1—obesity	0.000641	0.125	CrCbGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC6A14—obesity	0.000563	0.0156	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—G6PD—obesity	0.00053	0.0147	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC6A14—obesity	0.000523	0.0145	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A3—obesity	0.000467	0.0129	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC9A3—obesity	0.000441	0.0122	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—obesity	0.000434	0.012	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A3—obesity	0.000433	0.012	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GPX3—obesity	0.00043	0.0119	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—HK2—obesity	0.000421	0.0116	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC27A1—obesity	0.000403	0.0112	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—AQP7—obesity	0.00039	0.0108	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC6A4—obesity	0.00036	0.00997	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC16A7—obesity	0.000357	0.00987	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC16A7—obesity	0.000332	0.00919	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—LCN2—obesity	0.000332	0.00918	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—HK1—obesity	0.00033	0.00913	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—NQO1—obesity	0.000326	0.00902	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC2A4—obesity	0.000313	0.00865	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—COX7C—obesity	0.000312	0.00863	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC16A7—obesity	0.000308	0.00853	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GGT1—obesity	0.000303	0.00837	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC22A1—obesity	0.000292	0.00807	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—GABRA6—obesity	0.000282	0.0078	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—FTL—obesity	0.000282	0.0078	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—HMOX1—obesity	0.000268	0.00742	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—GCK—obesity	0.000253	0.00701	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC6A14—obesity	0.000252	0.00696	CbGpPWpGaD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—obesity	0.000245	0.00676	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC6A14—obesity	0.000234	0.00646	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC9A3—obesity	0.000224	0.0062	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—HK2—obesity	0.000214	0.00591	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC9A3—obesity	0.000209	0.00577	CbGpPWpGaD
Valganciclovir—SLC15A1—digestive system—obesity	0.000207	0.0795	CbGeAlD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC27A1—obesity	0.000205	0.00567	CbGpPWpGaD
Valganciclovir—SLC15A2—respiratory system—obesity	0.000204	0.0782	CbGeAlD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—HK2—obesity	0.000199	0.0055	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC2A4—obesity	0.000197	0.00545	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC9A3—obesity	0.000194	0.00535	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC27A1—obesity	0.000191	0.00528	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—HK2—obesity	0.000185	0.00511	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—AQP7—obesity	0.000185	0.0051	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC27A1—obesity	0.000177	0.0049	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—TRPV1—obesity	0.000174	0.00482	CbGpPWpGaD
Valganciclovir—SLC15A1—endocrine gland—obesity	0.000171	0.0657	CbGeAlD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—AQP7—obesity	0.000171	0.00474	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC16A7—obesity	0.000169	0.00467	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—HK1—obesity	0.000168	0.00464	CbGpPWpGaD
Valganciclovir—Cough—Orlistat—obesity	0.000167	0.00102	CcSEcCtD
Valganciclovir—Psychotic disorder—Topiramate—obesity	0.000167	0.00101	CcSEcCtD
Valganciclovir—Chills—Bupropion—obesity	0.000167	0.00101	CcSEcCtD
Valganciclovir—Vertigo—Sibutramine—obesity	0.000167	0.00101	CcSEcCtD
Valganciclovir—Convulsion—Orlistat—obesity	0.000166	0.00101	CcSEcCtD
Valganciclovir—Leukopenia—Sibutramine—obesity	0.000166	0.00101	CcSEcCtD
Valganciclovir—Arrhythmia—Bupropion—obesity	0.000166	0.00101	CcSEcCtD
Valganciclovir—Alopecia—Bupropion—obesity	0.000164	0.000997	CcSEcCtD
Valganciclovir—Mental disorder—Bupropion—obesity	0.000163	0.000988	CcSEcCtD
Valganciclovir—Anxiety—Orlistat—obesity	0.000162	0.000987	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000162	0.000984	CcSEcCtD
Valganciclovir—Cough—Sibutramine—obesity	0.000162	0.000983	CcSEcCtD
Valganciclovir—Malnutrition—Bupropion—obesity	0.000162	0.000982	CcSEcCtD
Valganciclovir—Discomfort—Orlistat—obesity	0.000161	0.000979	CcSEcCtD
Valganciclovir—Ataxia—Topiramate—obesity	0.000161	0.000977	CcSEcCtD
Valganciclovir—Convulsion—Sibutramine—obesity	0.000161	0.000976	CcSEcCtD
Valganciclovir—Blood creatinine increased—Topiramate—obesity	0.00016	0.000973	CcSEcCtD
Valganciclovir—Hypertension—Sibutramine—obesity	0.00016	0.000972	CcSEcCtD
Valganciclovir—Dry mouth—Orlistat—obesity	0.000159	0.000969	CcSEcCtD
Valganciclovir—Flatulence—Bupropion—obesity	0.000159	0.000968	CcSEcCtD
Valganciclovir—Dehydration—Topiramate—obesity	0.000159	0.000966	CcSEcCtD
Valganciclovir—Tension—Bupropion—obesity	0.000159	0.000964	CcSEcCtD
Valganciclovir—Dysgeusia—Bupropion—obesity	0.000158	0.000962	CcSEcCtD
Valganciclovir—Arthralgia—Sibutramine—obesity	0.000158	0.000959	CcSEcCtD
Valganciclovir—Anxiety—Sibutramine—obesity	0.000157	0.000956	CcSEcCtD
Valganciclovir—Nervousness—Bupropion—obesity	0.000157	0.000954	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—LCN2—obesity	0.000157	0.00434	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC16A7—obesity	0.000157	0.00433	CbGpPWpGaD
Valganciclovir—Anaphylactic shock—Orlistat—obesity	0.000156	0.00095	CcSEcCtD
Valganciclovir—Oedema—Orlistat—obesity	0.000156	0.00095	CcSEcCtD
Valganciclovir—Back pain—Bupropion—obesity	0.000156	0.00095	CcSEcCtD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—HK1—obesity	0.000156	0.00432	CbGpPWpGaD
Valganciclovir—Abdominal pain upper—Topiramate—obesity	0.000156	0.000949	CcSEcCtD
Valganciclovir—Discomfort—Sibutramine—obesity	0.000156	0.000947	CcSEcCtD
Valganciclovir—Hypokalaemia—Topiramate—obesity	0.000156	0.000945	CcSEcCtD
Valganciclovir—Muscle spasms—Bupropion—obesity	0.000155	0.000944	CcSEcCtD
Valganciclovir—Infection—Orlistat—obesity	0.000155	0.000944	CcSEcCtD
Valganciclovir—SLC15A1—liver—obesity	0.000155	0.0592	CbGeAlD
Valganciclovir—Dry mouth—Sibutramine—obesity	0.000154	0.000938	CcSEcCtD
Valganciclovir—Nervous system disorder—Orlistat—obesity	0.000153	0.000931	CcSEcCtD
Valganciclovir—Nasopharyngitis—Topiramate—obesity	0.000153	0.000929	CcSEcCtD
Valganciclovir—Confusional state—Sibutramine—obesity	0.000153	0.000927	CcSEcCtD
Valganciclovir—Vision blurred—Bupropion—obesity	0.000152	0.000925	CcSEcCtD
Valganciclovir—Skin disorder—Orlistat—obesity	0.000152	0.000923	CcSEcCtD
Valganciclovir—Tremor—Bupropion—obesity	0.000151	0.00092	CcSEcCtD
Valganciclovir—Gastritis—Topiramate—obesity	0.000151	0.000919	CcSEcCtD
Valganciclovir—Oedema—Sibutramine—obesity	0.000151	0.000919	CcSEcCtD
Valganciclovir—Anaphylactic shock—Sibutramine—obesity	0.000151	0.000919	CcSEcCtD
Valganciclovir—Hyperhidrosis—Orlistat—obesity	0.000151	0.000918	CcSEcCtD
Valganciclovir—Infection—Sibutramine—obesity	0.00015	0.000913	CcSEcCtD
Valganciclovir—Ill-defined disorder—Bupropion—obesity	0.00015	0.000911	CcSEcCtD
Valganciclovir—Anaemia—Bupropion—obesity	0.000149	0.000908	CcSEcCtD
Valganciclovir—Abdominal distension—Topiramate—obesity	0.000149	0.000904	CcSEcCtD
Valganciclovir—Agitation—Bupropion—obesity	0.000148	0.000902	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC22A1—obesity	0.000148	0.0041	CbGpPWpGaD
Valganciclovir—Thrombocytopenia—Sibutramine—obesity	0.000148	0.0009	CcSEcCtD
Valganciclovir—Dysphagia—Topiramate—obesity	0.000148	0.000898	CcSEcCtD
Valganciclovir—Tachycardia—Sibutramine—obesity	0.000148	0.000897	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—COX7C—obesity	0.000148	0.00408	CbGpPWpGaD
Valganciclovir—Skin disorder—Sibutramine—obesity	0.000147	0.000893	CcSEcCtD
Valganciclovir—Eosinophilia—Topiramate—obesity	0.000146	0.000889	CcSEcCtD
Valganciclovir—Hyperhidrosis—Sibutramine—obesity	0.000146	0.000889	CcSEcCtD
Valganciclovir—Malaise—Bupropion—obesity	0.000146	0.000885	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—LCN2—obesity	0.000146	0.00403	CbGpPWpGaD
Valganciclovir—Vertigo—Bupropion—obesity	0.000145	0.000882	CcSEcCtD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—HK1—obesity	0.000145	0.00401	CbGpPWpGaD
Valganciclovir—Pancreatitis—Topiramate—obesity	0.000145	0.00088	CcSEcCtD
Valganciclovir—Leukopenia—Bupropion—obesity	0.000145	0.000879	CcSEcCtD
Valganciclovir—Anorexia—Sibutramine—obesity	0.000144	0.000876	CcSEcCtD
Valganciclovir—Sweating increased—Topiramate—obesity	0.000144	0.000875	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Orlistat—obesity	0.000142	0.000865	CcSEcCtD
Valganciclovir—Bronchitis—Topiramate—obesity	0.000142	0.000863	CcSEcCtD
Valganciclovir—Insomnia—Orlistat—obesity	0.000141	0.000859	CcSEcCtD
Valganciclovir—Hypotension—Sibutramine—obesity	0.000141	0.000859	CcSEcCtD
Valganciclovir—Cough—Bupropion—obesity	0.000141	0.000857	CcSEcCtD
Valganciclovir—Paraesthesia—Orlistat—obesity	0.00014	0.000853	CcSEcCtD
Valganciclovir—Pancytopenia—Topiramate—obesity	0.00014	0.000853	CcSEcCtD
Valganciclovir—Convulsion—Bupropion—obesity	0.00014	0.000851	CcSEcCtD
Valganciclovir—Hypertension—Bupropion—obesity	0.000139	0.000848	CcSEcCtD
Valganciclovir—SLC15A2—pituitary gland—obesity	0.000138	0.053	CbGeAlD
Valganciclovir—Dysuria—Topiramate—obesity	0.000138	0.00084	CcSEcCtD
Valganciclovir—Neutropenia—Topiramate—obesity	0.000138	0.00084	CcSEcCtD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC22A1—obesity	0.000138	0.00382	CbGpPWpGaD
Valganciclovir—Musculoskeletal discomfort—Sibutramine—obesity	0.000138	0.000837	CcSEcCtD
Valganciclovir—Dyspepsia—Orlistat—obesity	0.000138	0.000836	CcSEcCtD
Valganciclovir—Arthralgia—Bupropion—obesity	0.000138	0.000836	CcSEcCtD
Valganciclovir—Upper respiratory tract infection—Topiramate—obesity	0.000137	0.000834	CcSEcCtD
Valganciclovir—Anxiety—Bupropion—obesity	0.000137	0.000833	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—COX7C—obesity	0.000137	0.00379	CbGpPWpGaD
Valganciclovir—Insomnia—Sibutramine—obesity	0.000137	0.000831	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—PRKAR2B—obesity	0.000137	0.00378	CbGpPWpGaD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000137	0.00083	CcSEcCtD
Valganciclovir—Pollakiuria—Topiramate—obesity	0.000136	0.000829	CcSEcCtD
Valganciclovir—Erectile dysfunction—Topiramate—obesity	0.000136	0.000827	CcSEcCtD
Valganciclovir—Discomfort—Bupropion—obesity	0.000136	0.000826	CcSEcCtD
Valganciclovir—Decreased appetite—Orlistat—obesity	0.000136	0.000826	CcSEcCtD
Valganciclovir—Paraesthesia—Sibutramine—obesity	0.000136	0.000825	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Orlistat—obesity	0.000135	0.00082	CcSEcCtD
Valganciclovir—Dyspnoea—Sibutramine—obesity	0.000135	0.00082	CcSEcCtD
Valganciclovir—Photosensitivity reaction—Topiramate—obesity	0.000135	0.000819	CcSEcCtD
Valganciclovir—Fatigue—Orlistat—obesity	0.000135	0.000819	CcSEcCtD
Valganciclovir—Dry mouth—Bupropion—obesity	0.000135	0.000818	CcSEcCtD
Valganciclovir—Somnolence—Sibutramine—obesity	0.000134	0.000817	CcSEcCtD
Valganciclovir—Weight decreased—Topiramate—obesity	0.000134	0.000812	CcSEcCtD
Valganciclovir—Pain—Orlistat—obesity	0.000134	0.000812	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—FTL—obesity	0.000133	0.00369	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—GABRA6—obesity	0.000133	0.00369	CbGpPWpGaD
Valganciclovir—Hyperglycaemia—Topiramate—obesity	0.000133	0.00081	CcSEcCtD
Valganciclovir—Dyspepsia—Sibutramine—obesity	0.000133	0.000809	CcSEcCtD
Valganciclovir—Confusional state—Bupropion—obesity	0.000133	0.000808	CcSEcCtD
Valganciclovir—Pneumonia—Topiramate—obesity	0.000132	0.000805	CcSEcCtD
Valganciclovir—Anaphylactic shock—Bupropion—obesity	0.000132	0.000801	CcSEcCtD
Valganciclovir—Oedema—Bupropion—obesity	0.000132	0.000801	CcSEcCtD
Valganciclovir—Infestation—Topiramate—obesity	0.000132	0.0008	CcSEcCtD
Valganciclovir—Infestation NOS—Topiramate—obesity	0.000132	0.0008	CcSEcCtD
Valganciclovir—Decreased appetite—Sibutramine—obesity	0.000131	0.000799	CcSEcCtD
Valganciclovir—Depression—Topiramate—obesity	0.000131	0.000798	CcSEcCtD
Valganciclovir—Infection—Bupropion—obesity	0.000131	0.000796	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Sibutramine—obesity	0.000131	0.000794	CcSEcCtD
Valganciclovir—Renal failure—Topiramate—obesity	0.000129	0.000787	CcSEcCtD
Valganciclovir—Pain—Sibutramine—obesity	0.000129	0.000786	CcSEcCtD
Valganciclovir—Constipation—Sibutramine—obesity	0.000129	0.000786	CcSEcCtD
Valganciclovir—Nervous system disorder—Bupropion—obesity	0.000129	0.000786	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Topiramate—obesity	0.000129	0.000785	CcSEcCtD
Valganciclovir—Thrombocytopenia—Bupropion—obesity	0.000129	0.000785	CcSEcCtD
Valganciclovir—Feeling abnormal—Orlistat—obesity	0.000129	0.000783	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—GCK—obesity	0.000129	0.00356	CbGpPWpGaD
Valganciclovir—Tachycardia—Bupropion—obesity	0.000129	0.000782	CcSEcCtD
Valganciclovir—Stomatitis—Topiramate—obesity	0.000128	0.00078	CcSEcCtD
Valganciclovir—Skin disorder—Bupropion—obesity	0.000128	0.000778	CcSEcCtD
Valganciclovir—Urinary tract infection—Topiramate—obesity	0.000128	0.000778	CcSEcCtD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC22A1—obesity	0.000128	0.00354	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC6A14—obesity	0.000128	0.00354	CbGpPWpGaD
Valganciclovir—Gastrointestinal pain—Orlistat—obesity	0.000128	0.000777	CcSEcCtD
Valganciclovir—Hyperhidrosis—Bupropion—obesity	0.000127	0.000775	CcSEcCtD
Valganciclovir—Anorexia—Bupropion—obesity	0.000126	0.000764	CcSEcCtD
Valganciclovir—Haematuria—Topiramate—obesity	0.000126	0.000763	CcSEcCtD
Valganciclovir—Feeling abnormal—Sibutramine—obesity	0.000125	0.000757	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—CETP—obesity	0.000124	0.00344	CbGpPWpGaD
Valganciclovir—Urticaria—Orlistat—obesity	0.000124	0.000755	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—FTL—obesity	0.000124	0.00343	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—GABRA6—obesity	0.000124	0.00343	CbGpPWpGaD
Valganciclovir—Gastrointestinal pain—Sibutramine—obesity	0.000124	0.000752	CcSEcCtD
Valganciclovir—Sinusitis—Topiramate—obesity	0.000124	0.000751	CcSEcCtD
Valganciclovir—Abdominal pain—Orlistat—obesity	0.000124	0.000751	CcSEcCtD
Valganciclovir—Body temperature increased—Orlistat—obesity	0.000124	0.000751	CcSEcCtD
Valganciclovir—SLC15A2—adrenal gland—obesity	0.000124	0.0474	CbGeAlD
Valganciclovir—Hypotension—Bupropion—obesity	0.000123	0.000749	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—TF—obesity	0.000123	0.0034	CbGpPWpGaD
Valganciclovir—Urticaria—Sibutramine—obesity	0.00012	0.00073	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Bupropion—obesity	0.00012	0.00073	CcSEcCtD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—GCK—obesity	0.00012	0.00331	CbGpPWpGaD
Valganciclovir—Body temperature increased—Sibutramine—obesity	0.00012	0.000727	CcSEcCtD
Valganciclovir—Abdominal pain—Sibutramine—obesity	0.00012	0.000727	CcSEcCtD
Valganciclovir—Insomnia—Bupropion—obesity	0.000119	0.000725	CcSEcCtD
Valganciclovir—Haemoglobin—Topiramate—obesity	0.000119	0.000722	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC6A14—obesity	0.000119	0.00328	CbGpPWpGaD
Valganciclovir—Paraesthesia—Bupropion—obesity	0.000118	0.00072	CcSEcCtD
Valganciclovir—Haemorrhage—Topiramate—obesity	0.000118	0.000719	CcSEcCtD
Valganciclovir—Hepatitis—Topiramate—obesity	0.000118	0.000719	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—TFRC—obesity	0.000118	0.00326	CbGpPWpGaD
Valganciclovir—Hallucination—Topiramate—obesity	0.000118	0.000715	CcSEcCtD
Valganciclovir—Dyspnoea—Bupropion—obesity	0.000118	0.000714	CcSEcCtD
Valganciclovir—Pharyngitis—Topiramate—obesity	0.000117	0.000713	CcSEcCtD
Valganciclovir—Somnolence—Bupropion—obesity	0.000117	0.000712	CcSEcCtD
Valganciclovir—Urinary tract disorder—Topiramate—obesity	0.000117	0.00071	CcSEcCtD
Valganciclovir—Oedema peripheral—Topiramate—obesity	0.000116	0.000708	CcSEcCtD
Valganciclovir—Connective tissue disorder—Topiramate—obesity	0.000116	0.000706	CcSEcCtD
Valganciclovir—Dyspepsia—Bupropion—obesity	0.000116	0.000705	CcSEcCtD
Valganciclovir—Urethral disorder—Topiramate—obesity	0.000116	0.000704	CcSEcCtD
Valganciclovir—Hypersensitivity—Orlistat—obesity	0.000115	0.0007	CcSEcCtD
Valganciclovir—Decreased appetite—Bupropion—obesity	0.000115	0.000697	CcSEcCtD
Valganciclovir—Visual impairment—Topiramate—obesity	0.000114	0.000693	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Bupropion—obesity	0.000114	0.000692	CcSEcCtD
Valganciclovir—Fatigue—Bupropion—obesity	0.000114	0.000691	CcSEcCtD
Valganciclovir—Constipation—Bupropion—obesity	0.000113	0.000685	CcSEcCtD
Valganciclovir—Pain—Bupropion—obesity	0.000113	0.000685	CcSEcCtD
Valganciclovir—Asthenia—Orlistat—obesity	0.000112	0.000681	CcSEcCtD
Valganciclovir—Hypersensitivity—Sibutramine—obesity	0.000111	0.000677	CcSEcCtD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—GCK—obesity	0.000111	0.00308	CbGpPWpGaD
Valganciclovir—Pruritus—Orlistat—obesity	0.000111	0.000672	CcSEcCtD
Valganciclovir—Eye disorder—Topiramate—obesity	0.000111	0.000672	CcSEcCtD
Valganciclovir—Tinnitus—Topiramate—obesity	0.00011	0.00067	CcSEcCtD
Valganciclovir—Cardiac disorder—Topiramate—obesity	0.00011	0.000667	CcSEcCtD
Valganciclovir—Feeling abnormal—Bupropion—obesity	0.000109	0.00066	CcSEcCtD
Valganciclovir—Asthenia—Sibutramine—obesity	0.000109	0.00066	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Bupropion—obesity	0.000108	0.000655	CcSEcCtD
Valganciclovir—Angiopathy—Topiramate—obesity	0.000107	0.000652	CcSEcCtD
Valganciclovir—SLC15A2—endocrine gland—obesity	0.000107	0.0411	CbGeAlD
Valganciclovir—Pruritus—Sibutramine—obesity	0.000107	0.00065	CcSEcCtD
Valganciclovir—Diarrhoea—Orlistat—obesity	0.000107	0.00065	CcSEcCtD
Valganciclovir—Immune system disorder—Topiramate—obesity	0.000107	0.000649	CcSEcCtD
Valganciclovir—Mediastinal disorder—Topiramate—obesity	0.000107	0.000648	CcSEcCtD
Valganciclovir—Chills—Topiramate—obesity	0.000106	0.000645	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC9A3—obesity	0.000106	0.00293	CbGpPWpGaD
Valganciclovir—Urticaria—Bupropion—obesity	0.000105	0.000637	CcSEcCtD
Valganciclovir—Alopecia—Topiramate—obesity	0.000104	0.000635	CcSEcCtD
Valganciclovir—Abdominal pain—Bupropion—obesity	0.000104	0.000633	CcSEcCtD
Valganciclovir—Body temperature increased—Bupropion—obesity	0.000104	0.000633	CcSEcCtD
Valganciclovir—Mental disorder—Topiramate—obesity	0.000104	0.00063	CcSEcCtD
Valganciclovir—Diarrhoea—Sibutramine—obesity	0.000103	0.000629	CcSEcCtD
Valganciclovir—Dizziness—Orlistat—obesity	0.000103	0.000628	CcSEcCtD
Valganciclovir—Malnutrition—Topiramate—obesity	0.000103	0.000626	CcSEcCtD
Valganciclovir—SLC6A14—NRF2 pathway—TGFB1—obesity	0.000102	0.00282	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—ALB—obesity	0.000101	0.00281	CbGpPWpGaD
Valganciclovir—Flatulence—Topiramate—obesity	0.000101	0.000616	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—HK2—obesity	0.000101	0.0028	CbGpPWpGaD
Valganciclovir—Tension—Topiramate—obesity	0.000101	0.000614	CcSEcCtD
Valganciclovir—Dysgeusia—Topiramate—obesity	0.000101	0.000613	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC2A4—obesity	0.0001	0.00277	CbGpPWpGaD
Valganciclovir—Dizziness—Sibutramine—obesity	0.0001	0.000608	CcSEcCtD
Valganciclovir—Nervousness—Topiramate—obesity	0.0001	0.000608	CcSEcCtD
Valganciclovir—Back pain—Topiramate—obesity	9.96e-05	0.000605	CcSEcCtD
Valganciclovir—Vomiting—Orlistat—obesity	9.94e-05	0.000604	CcSEcCtD
Valganciclovir—Muscle spasms—Topiramate—obesity	9.9e-05	0.000601	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—CYCS—obesity	9.88e-05	0.00273	CbGpPWpGaD
Valganciclovir—Dermatitis—Orlistat—obesity	9.85e-05	0.000598	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC9A3—obesity	9.84e-05	0.00272	CbGpPWpGaD
Valganciclovir—Headache—Orlistat—obesity	9.79e-05	0.000595	CcSEcCtD
Valganciclovir—Hypersensitivity—Bupropion—obesity	9.72e-05	0.00059	CcSEcCtD
Valganciclovir—Vision blurred—Topiramate—obesity	9.7e-05	0.00059	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC27A1—obesity	9.69e-05	0.00268	CbGpPWpGaD
Valganciclovir—Tremor—Topiramate—obesity	9.64e-05	0.000586	CcSEcCtD
Valganciclovir—Vomiting—Sibutramine—obesity	9.62e-05	0.000584	CcSEcCtD
Valganciclovir—Ill-defined disorder—Topiramate—obesity	9.55e-05	0.00058	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—NCOA1—obesity	9.55e-05	0.00264	CbGpPWpGaD
Valganciclovir—Dermatitis—Sibutramine—obesity	9.53e-05	0.000579	CcSEcCtD
Valganciclovir—Anaemia—Topiramate—obesity	9.51e-05	0.000578	CcSEcCtD
Valganciclovir—Headache—Sibutramine—obesity	9.48e-05	0.000576	CcSEcCtD
Valganciclovir—Asthenia—Bupropion—obesity	9.46e-05	0.000575	CcSEcCtD
Valganciclovir—Agitation—Topiramate—obesity	9.46e-05	0.000575	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—HK2—obesity	9.38e-05	0.0026	CbGpPWpGaD
Valganciclovir—Pruritus—Bupropion—obesity	9.33e-05	0.000567	CcSEcCtD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—obesity	9.32e-05	0.00258	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—PLG—obesity	9.31e-05	0.00257	CbGpPWpGaD
Valganciclovir—Nausea—Orlistat—obesity	9.28e-05	0.000564	CcSEcCtD
Valganciclovir—Malaise—Topiramate—obesity	9.28e-05	0.000564	CcSEcCtD
Valganciclovir—Vertigo—Topiramate—obesity	9.25e-05	0.000562	CcSEcCtD
Valganciclovir—Leukopenia—Topiramate—obesity	9.21e-05	0.00056	CcSEcCtD
Valganciclovir—Diarrhoea—Bupropion—obesity	9.02e-05	0.000548	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC27A1—obesity	9e-05	0.00249	CbGpPWpGaD
Valganciclovir—Nausea—Sibutramine—obesity	8.98e-05	0.000546	CcSEcCtD
Valganciclovir—Cough—Topiramate—obesity	8.98e-05	0.000546	CcSEcCtD
Valganciclovir—Convulsion—Topiramate—obesity	8.92e-05	0.000542	CcSEcCtD
Valganciclovir—Hypertension—Topiramate—obesity	8.89e-05	0.00054	CcSEcCtD
Valganciclovir—Arthralgia—Topiramate—obesity	8.76e-05	0.000533	CcSEcCtD
Valganciclovir—Anxiety—Topiramate—obesity	8.73e-05	0.000531	CcSEcCtD
Valganciclovir—Dizziness—Bupropion—obesity	8.72e-05	0.00053	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	8.7e-05	0.000529	CcSEcCtD
Valganciclovir—Discomfort—Topiramate—obesity	8.66e-05	0.000526	CcSEcCtD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—obesity	8.65e-05	0.00239	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—GNB3—obesity	8.63e-05	0.00239	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—HMOX1—obesity	8.59e-05	0.00238	CbGpPWpGaD
Valganciclovir—Dry mouth—Topiramate—obesity	8.57e-05	0.000521	CcSEcCtD
Valganciclovir—Confusional state—Topiramate—obesity	8.47e-05	0.000515	CcSEcCtD
Valganciclovir—Oedema—Topiramate—obesity	8.4e-05	0.000511	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—GNAS—obesity	8.4e-05	0.00232	CbGpPWpGaD
Valganciclovir—Vomiting—Bupropion—obesity	8.38e-05	0.00051	CcSEcCtD
Valganciclovir—Infection—Topiramate—obesity	8.35e-05	0.000507	CcSEcCtD
Valganciclovir—Dermatitis—Bupropion—obesity	8.31e-05	0.000505	CcSEcCtD
Valganciclovir—Headache—Bupropion—obesity	8.26e-05	0.000502	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—TRPV1—obesity	8.24e-05	0.00228	CbGpPWpGaD
Valganciclovir—Nervous system disorder—Topiramate—obesity	8.24e-05	0.000501	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—APOB—obesity	8.23e-05	0.00228	CbGpPWpGaD
Valganciclovir—Thrombocytopenia—Topiramate—obesity	8.23e-05	0.0005	CcSEcCtD
Valganciclovir—Tachycardia—Topiramate—obesity	8.2e-05	0.000498	CcSEcCtD
Valganciclovir—Skin disorder—Topiramate—obesity	8.16e-05	0.000496	CcSEcCtD
Valganciclovir—Hyperhidrosis—Topiramate—obesity	8.12e-05	0.000494	CcSEcCtD
Valganciclovir—Anorexia—Topiramate—obesity	8.01e-05	0.000487	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—HK1—obesity	7.93e-05	0.00219	CbGpPWpGaD
Valganciclovir—Hypotension—Topiramate—obesity	7.85e-05	0.000477	CcSEcCtD
Valganciclovir—Nausea—Bupropion—obesity	7.83e-05	0.000476	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Topiramate—obesity	7.65e-05	0.000465	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—TRPV1—obesity	7.65e-05	0.00212	CbGpPWpGaD
Valganciclovir—Insomnia—Topiramate—obesity	7.6e-05	0.000462	CcSEcCtD
Valganciclovir—Paraesthesia—Topiramate—obesity	7.54e-05	0.000458	CcSEcCtD
Valganciclovir—Dyspnoea—Topiramate—obesity	7.49e-05	0.000455	CcSEcCtD
Valganciclovir—Somnolence—Topiramate—obesity	7.47e-05	0.000454	CcSEcCtD
Valganciclovir—Dyspepsia—Topiramate—obesity	7.4e-05	0.000449	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—HK1—obesity	7.36e-05	0.00204	CbGpPWpGaD
Valganciclovir—Decreased appetite—Topiramate—obesity	7.3e-05	0.000444	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Topiramate—obesity	7.25e-05	0.000441	CcSEcCtD
Valganciclovir—Fatigue—Topiramate—obesity	7.24e-05	0.00044	CcSEcCtD
Valganciclovir—Pain—Topiramate—obesity	7.18e-05	0.000437	CcSEcCtD
Valganciclovir—Constipation—Topiramate—obesity	7.18e-05	0.000437	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC22A1—obesity	7.01e-05	0.00194	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—PPARA—obesity	6.94e-05	0.00192	CbGpPWpGaD
Valganciclovir—Feeling abnormal—Topiramate—obesity	6.92e-05	0.000421	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Topiramate—obesity	6.87e-05	0.000417	CcSEcCtD
Valganciclovir—Urticaria—Topiramate—obesity	6.67e-05	0.000406	CcSEcCtD
Valganciclovir—Body temperature increased—Topiramate—obesity	6.64e-05	0.000404	CcSEcCtD
Valganciclovir—Abdominal pain—Topiramate—obesity	6.64e-05	0.000404	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—APOA1—obesity	6.51e-05	0.0018	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC22A1—obesity	6.5e-05	0.0018	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—PRKAR2B—obesity	6.47e-05	0.00179	CbGpPWpGaD
Valganciclovir—Hypersensitivity—Topiramate—obesity	6.19e-05	0.000376	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—GCK—obesity	6.09e-05	0.00168	CbGpPWpGaD
Valganciclovir—Asthenia—Topiramate—obesity	6.03e-05	0.000366	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—PRKAR2B—obesity	6e-05	0.00166	CbGpPWpGaD
Valganciclovir—Pruritus—Topiramate—obesity	5.94e-05	0.000361	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—CETP—obesity	5.87e-05	0.00162	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—TF—obesity	5.81e-05	0.00161	CbGpPWpGaD
Valganciclovir—Diarrhoea—Topiramate—obesity	5.75e-05	0.000349	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—GCK—obesity	5.65e-05	0.00156	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—TFRC—obesity	5.57e-05	0.00154	CbGpPWpGaD
Valganciclovir—Dizziness—Topiramate—obesity	5.56e-05	0.000338	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—CETP—obesity	5.45e-05	0.00151	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—TF—obesity	5.39e-05	0.00149	CbGpPWpGaD
Valganciclovir—Vomiting—Topiramate—obesity	5.34e-05	0.000325	CcSEcCtD
Valganciclovir—Dermatitis—Topiramate—obesity	5.29e-05	0.000322	CcSEcCtD
Valganciclovir—Headache—Topiramate—obesity	5.26e-05	0.00032	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—TFRC—obesity	5.17e-05	0.00143	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ALB—obesity	5.16e-05	0.00143	CbGpPWpGaD
Valganciclovir—Nausea—Topiramate—obesity	4.99e-05	0.000303	CcSEcCtD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—ALB—obesity	4.8e-05	0.00133	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC2A4—obesity	4.73e-05	0.00131	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—CYCS—obesity	4.67e-05	0.00129	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—NCOA1—obesity	4.52e-05	0.00125	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—ALB—obesity	4.45e-05	0.00123	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—PLG—obesity	4.4e-05	0.00122	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC2A4—obesity	4.39e-05	0.00122	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—CYCS—obesity	4.34e-05	0.0012	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—NCOA1—obesity	4.19e-05	0.00116	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—PLG—obesity	4.08e-05	0.00113	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—GNB3—obesity	4.08e-05	0.00113	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—HMOX1—obesity	4.06e-05	0.00112	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—GNAS—obesity	3.97e-05	0.0011	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—APOB—obesity	3.89e-05	0.00108	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—GNB3—obesity	3.79e-05	0.00105	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—HMOX1—obesity	3.77e-05	0.00104	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—GNAS—obesity	3.69e-05	0.00102	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—APOB—obesity	3.61e-05	0.000999	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—PPARA—obesity	3.28e-05	0.000908	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—APOA1—obesity	3.08e-05	0.000852	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—PPARA—obesity	3.05e-05	0.000842	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—APOA1—obesity	2.86e-05	0.00079	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ALB—obesity	2.44e-05	0.000675	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ALB—obesity	2.26e-05	0.000626	CbGpPWpGaD
